Valuation (19%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | N/A | 37.63 |
PEG Ratio (TTM) | N/A | -3.12 |
P/S Ratio (TTM) | 20.07 | 48.28 |
P/B Ratio (TTM) | N/A | 0.97 |
P/FCF Ratio (TTM) | 2.38 | 12.76 |
Price to 5YR AVG Earnings Ratio | N/A | 25.52 |
Price to 5YR AVG FCF Ratio | N/A | 26.29 |
Profitability (40%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.98% | 2.02% |
ROE (TTM) | 4.64% | 6.44% |
Net Profit Margin (TTM) | 96.72% | 46.88% |
ROIC 5YR AVG | N/A | 8.51% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | N/A | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | N/A | N/A | N/A |
Cash Flow | N/A | N/A | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.77 | 2.19 |
Quick Ratio (TTM) | 1.06 | 2.10 |
D/E Ratio (TTM) | 0.12 | 0.73 |
Interest Coverage (TTM) | 4.70 | 21.29 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 2.68 | 7.87 |
LTL to 5YR AVG FCF | N/A | 8.97 |
Shares Outstanding Growth 5YR AVG | N/A | -1.65% |